Login

Enzymatica presents positive in-vitro results | August 2023 - Claus Egstrand,CEO, Enzymatica AB (publ) 00:00:00

Share On Facebook Share On Twitter

Enzymatica presents positive in-vitro results | August 2023

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Transitioning to Retirement with Confidence: Guidance from Michael Brady & Co. | Mike Brady, President, Michael Brady & Co.
00:10:00
Venture Lending and Support: Insights from Lighthouse Capital's Approach
00:10:00
Arie Kotler Addresses February Consumer Spending Decline and ARKO's EV Infrastructure Plans | Arie Kotler, CEO, ARKO Corp.
00:10:00
Geoff Yang on AI's Rise: Transformative Trends in Technology and Investment | Geoff Yang, Co-Founder, Redpoint Ventures.
00:10:00
part 2 : Tax Planning Tips with Maggie Klokkenga, CFP®, CPA, AFC® | Abundo Wealth | Maggie Klokkenga - Financial Planner at Abundo Wealth
00:10:00
Searchlight Resources' Uranium and Rare Earth Potential in the Wallaston Domain
00:10:00
Understanding Financial Aid Verification: What You Need to Know
00:10:00
Mitek Systems CEO Max Carnecchia discusses the forward outlook and company strategy on TheWatchList with Nicole Petallides.
00:10:00
Investing in Emerging Markets: Insights from James Donald of Lazard | James Donald - Fund Manager, Lazard Emerging Markets Fund
00:10:00
A2A's Alumni to Alumni features inspiration and insights, with a CEO spotlight on Priscilla Almodovar joining Fannie Mae as CEO.
00:10:00
An extract of a video podcast conversational piece filmed in Sydney for Cohort PLC. | Andrew Thomis, CEO, Cohort PLCCHRT:LSE
00:10:00
Setting Financial Goals with Expert Guidance: Insights from ICF Coach Sarah Fincher | Michelle Smalenberger, CEO, Financial Design Studio.

© 2026 Nehu